Article Correctness Is Author's Responsibility: Researchers Probe Emerging Mesothelioma Treatment Targeting PP2A and CDK

A collaborative study of researchers from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular Medicine of Temple University, University of Siena, and from the Spanish Center for the Applied Medical Research (CIMA) of the University of Navarra have discovered a novel targetable axis in mesothelioma patients.